Active ingredientCapromorelinCat. No. P-C027-001CAS 193273-66-4Family · Pharmaceutical analytical standards
Capromorelin
A ghrelin receptor agonist, first studied in humans against age-related physical decline and then developed for veterinary use: approved in the United States in 2016, it stimulates appetite and helps manage weight loss in dogs and cats. This family brings together the active ingredient.
Did you know?It mimics ghrelin, the hunger hormone made mainly by the stomach: in 2020 it became the first drug approved in the United States specifically for weight loss in cats with chronic kidney disease.
Go to the active ingredient →Active ingredientCapromorelinCat. No. P-C027-001CAS 193273-66-4
Active ingredientCapromorelin TartrateCat. No. P-C027-002CAS 193273-69-7No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.